Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU. Tai S, et al. Among authors: vemuri k. Psychopharmacology (Berl). 2015 Aug;232(15):2751-61. doi: 10.1007/s00213-015-3907-0. Epub 2015 Mar 15. Psychopharmacology (Berl). 2015. PMID: 25772338 Free PMC article.
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z. Schindler CW, et al. Among authors: vemuri k. Neuropsychopharmacology. 2016 Aug;41(9):2283-93. doi: 10.1038/npp.2016.27. Epub 2016 Feb 18. Neuropsychopharmacology. 2016. PMID: 26888056 Free PMC article.
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538.
Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Paronis CA, et al. Among authors: vemuri k. J Pharmacol Exp Ther. 2018 Mar;364(3):485-493. doi: 10.1124/jpet.117.245647. Epub 2018 Jan 8. J Pharmacol Exp Ther. 2018. PMID: 29311110 Free PMC article.
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates.
Kangas BD, Zakarian AS, Vemuri K, Alapafuja SO, Jiang S, Nikas SP, Makriyannis A, Bergman J. Kangas BD, et al. Among authors: vemuri k. J Pharmacol Exp Ther. 2020 Jan;372(1):119-127. doi: 10.1124/jpet.119.261818. Epub 2019 Oct 22. J Pharmacol Exp Ther. 2020. PMID: 31641018 Free PMC article.
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B. Gueye AB, et al. Among authors: vemuri k. Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw068. doi: 10.1093/ijnp/pyw068. Print 2016 Dec. Int J Neuropsychopharmacol. 2016. PMID: 27493155 Free PMC article.
80 results